The Alcohol Use Disorder market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Alcohol Use Disorder market dynamics. 

 

DelveInsight’s “Alcohol Use Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology as well as the Alcohol Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Key highlights of the Alcohol Use Disorder Market Report

• According to the National Survey on Drug Use and Health (NSDUH) (2019), 14.5 million people aged 12 and older (5.3 percent of this age group) had AUD. This number includes 9.0 million men (6.8 percent of men) and 5.5 million women (3.9 percent of women).
• Also, according to the NSDUH (2019), about 7.3 percent of adults ages 18 and older who had AUD in the past year received any treatment in the past year. This includes about 6.9 percent of males and 7.9 percent of females with past-year AUD in this age group. Less than 4 percent of people with AUD were prescribed a medication approved by the US FDA to treat their disorder.
• According to research studies, it is evident that, males are more affected with Alcohol Use Disorder (AUD) as compared to females.

 

Download Sample Report- https://www.delveinsight.com/sample-request/alcohol-use-disorder-market

 

Key benefits of the Alcohol Use Disorder Market report:

• Alcohol Use Disorder market report covers a descriptive overview and comprehensive insight of the Alcohol Use Disorder Epidemiology and Psoriatic Arthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
• The Alcohol Use Disorder market report provides insights on the current and emerging therapies.
• Alcohol Use Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.
• The Alcohol Use Disorder market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Alcohol Use Disorder market

 

Alcohol Use Disorder Overview

Alcohol Use Disorder is a medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. It encompasses the conditions that some people refer to as alcohol abuse, alcohol dependence, alcohol addiction, and the colloquial term, alcoholism.

 

Alcohol Use Disorder Epidemiology Segmentation in the 7MM

• Total Alcohol Use Disorder Diagnosed Prevalent cases
• Alcohol Use Disorder Severity-specific Diagnosed Prevalent Cases
• Alcohol Use Disorder Gender-specific Diagnosed Prevalent Cases
• Alcohol Use Disorder Treated cases

 

Alcohol Use Disorder Treatment Market

The current treatment options for Alcohol Use Disorder include medication-assisted treatment, behavioral interventions, detox and psychosocial assistance from rehab and support groups. The US FDA approved medication-assisted treatment includes ANTABUSE (disulfiram), REVIA (oral naltrexone), CAMPRAL (acamprosate calcium), and VIVITROL (extended-release injectable naltrexone). While SELINCRO (nalmefene) and BACLOCUR (baclofen) are approved in the EU for the treatment of AUD. In addition other drugs and antidepressants are also prescribed off-label.

 

Alcohol Use Disorder Market Dynamics

Alcohol Use Disorder market dynamics are anticipated to change in the coming years due to the rising awareness to treat addicted youth and initiatives by government and nongovernment organization to control alcohol/drug abuse.

 

Alcohol Use Disorder Market Size

The Alcohol Use Disorder market size is likely to grow during the forecast period i.e., 2019–2032 owing to the launch of upcoming therapies, increasing prevalence of alcohol abuse, changing lifestyle, increasing disposable income, and higher young population.

 

Alcohol Use Disorder Emerging Therapies

• MN-166 (Ibudilast) (MediciNova)
• ASP8062 (Astellas Pharma)
• DCR-AUD (Novo Nordisk)

 

Alcohol Use Disorder Market Insights

Alcohol use disorders are an important cause of morbidity and mortality. Despite the National Institute on Alcohol Abuse and Alcoholism (NIAAA) recommendations that medications be considered for patients with alcohol dependence, the mainstay of treatment has been counseling. Greater education about pharmacotherapy, including predictors for treatment response amongst patients, should help alleviate some of the uncertainties reported with medications’ efficacy and lead to a more combined treatment approach with drugs and counseling.

 

 Alcohol Use Disorder Emerging Therapy Assessment

Currently, pipeline products in clinical development include MN-166, ASP8062, DCR-AUD, and others. It is expected that the launch of these drugs is likely to expand market size during the forecast period due to an increase in treatment pool and disease awareness.

 

Alcohol Use Disorder Market Companies

• Merck sante
• Odyssey pharmaceuticals
• Dupont
• MediciNova
• Adial Pharmaceuticals
• Tonix Pharmaceuticals, and several others

 

Request Sample Report- https://www.delveinsight.com/sample-request/alcohol-use-disorder-market

 

Table of Content

1. Key Insights

2. Executive Summary of Alcohol Use Disorder

3. Competitive Intelligence Analysis for Alcohol Use Disorder

4. Alcohol Use Disorder Market Overview at a Glance

5. Alcohol Use Disorder Disease Background and Overview

6. Patient Journey

7. Alcohol Use Disorder Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Alcohol Use Disorder Unmet Needs

10. Key Endpoints of Alcohol Use Disorder Treatment

11. Alcohol Use Disorder Marketed Products

12. Alcohol Use Disorder Emerging Therapies

13. Alcohol Use Disorder (AUD): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Alcohol Use Disorder Market Outlook

16. Access and Reimbursement Overview

17. KOL Views

18. Alcohol Use Disorder Market Drivers

19. Alcohol Use Disorder Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Alcohol Use Disorder Market Report Highlights

• In the coming years, the Alcohol Use Disorder (AUD) market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Alcohol Use Disorder (AUD) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition     
• Major players are involved in developing therapies for Alcohol Use Disorder (AUD). The launch of emerging therapies will significantly impact the Alcohol Use Disorder (AUD) market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Alcohol Use Disorder (AUD)
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

 

Why should you buy this report?

• The report will help in developing business strategies by understanding trends shaping and driving the Alcohol Use Disorder market
• To understand the future market competition in the Alcohol Use Disorder market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Alcohol Use Disorder in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Alcohol Use Disorder market
• To understand the future market competition in the Alcohol Use Disorder market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

 

Contact Us

Yash

info@delveinsight.com

Media Contact
Company Name: DelveInsight
Contact Person: Yash
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/